International Diabetes Federation. IDF Diabetes Atlas 11th edition. (2025). https://diabetesatlas.org/resources/idf-diabetes-atlas-2025/
Safiri, S. et al. Prevalence, deaths and disability-adjusted-life-years (DALYs) due to type 2 diabetes and its attributable risk factors in 204 countries and territories, 1990–2019: results from the global burden of disease study 2019. Front. Endocrinol. 13, 838027 (2022).
Fowler, M. J. Microvascular and macrovascular complications of diabetes. Clin. Diabetes. 26, 77–82 (2008).
Tomic, D., Shaw, J. E. & Magliano, D. J. The burden and risks of emerging complications of diabetes mellitus. Nat. Rev. Endocrinol. 18, 525–539 (2022).
Li, R. et al. Global diabetes prevalence in COVID-19 patients and contribution to COVID-19– related severity and mortality: A systematic review and Meta-analysis. Diabetes Care. 46, 890–897 (2023).
Franco, J. V. A. et al. Post-covid-19 conditions in adults: systematic review and metaanalysis of health outcomes in controlled studies. BMJ medicine. 3, e000723 (2024).
Rotella, F. & Mannucci, E. Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies. Diabetes Res. Clin. Pract. 99, 98–104 (2013).
Smith, K. J. et al. Association of diabetes with anxiety: a systematic review and meta-analysis. J. Psychosom. Res. 74, 89–99 (2013).
Harding, K. A. et al. Depression prevalence in type 2 diabetes is not related to diabetes–depression symptom overlaps but is related to symptom dimensions within patient self-report measures: a meta-analysis. Diabet. Med. 36, 1600–1611 (2019).
Roy, B. et al. Regional brain gray matter changes in patients with type 2 diabetes mellitus. Sci. Rep. 10, 9925 (2020).
Zhang, D. et al. Altered Cerebellar-Cerebral circuits in patients with type 2 diabetes mellitus. Front. Neurosci. 14, 571210 (2020).
Behnoush, A. H. et al. The importance of assessing the triglyceride-glucose index (TyG) in patients with depression: A systematic review. Neurosci. Biobehav. Rev. 159, 105582 (2024).
Katon, W. J. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol. Psychiatry. 54 (3), 216–226 (2003).
Schram, M. T., Baan, C. A. & Pouwer, F. Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium. Curr. Diabetes Rev. 5 (2), 112–119 (2009).
Fukunaga, A. et al. Diabetes, prediabetes, and long-term sickness absence due to mental disorders: Japan epidemiology collaboration on occupational health study. J. Psychosom. Res. 158, 110925 (2022).
Feldman-Billarda, S. & Dupas, B. Eye disorders other than diabetic retinopathy in patients with diabetes. Diabetes Metab. 47, 101279 (2021).
Candrilli, S. D., Davis, K. L., Kan, H. J., Lucero, M. A. & Rousculp, M. D. Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy. J. Diabetes Complications. 21 (5), 306–314 (2007).
Díaz de León, V., Jáuregui-Renaud, K., Garay-Sevilla, M. E., Hernández-Prado, J. & Malacara-Hernández, J. Auditory impairment in patients with type 2 diabetes mellitus. Arch. Med. Res. 36 (5), 507–510 (2005).
Mahoney, J. R., Verghese, J. & George, C. The influence of diabetes on multisensory integration and mobility in aging. Brain Sci. 11, 285 (2021).
Jáuregui-Renaud, K., Dominguez-Rubio, B. & Ibarra-Olmos, A. González-Barcena, D. Trastornos otoneurológicos de pacientes con diabetes mellitus insulino-dependiente. Rev. Inv Clin. 50, 137–138 (1998).
Agrawal, Y., Carey, J. P., Della Santina, C. C., Schubert, M. C. & Minor, L. B. Disorders of balance and vestibular function in US adults: data from the National health and nutrition examination survey, 2001–2004. Arch. Intern. Med. 169 (10), 938–944 (2009).
Jáuregui-Renaud, K., Aranda-Moreno, C. & Herrera-Rangel, A. B. Utricular hypofunction in patients with type 2 diabetes mellitus. Acta Otorhinolaryngol. Ital. 37 (5), 430–435 (2017).
Horikawa, C. et al. Diabetes and risk of hearing impairment in adults: A Meta-Analysis. J. Clin. Endocrinol. Metab. 98, 51–58 (2013).
Assi, L. et al. A global assessment of eye health and quality of life: A systematic review of systematic reviews. JAMA Ophthalmol. 139 (5), 526–541 (2021).
Khoo, K. et al. The relationship between diabetic retinopathy and psychosocial functioning: a systematic review. Qual Life Res. 28 (8), 2017–2039 (2019).
Perveen, W. et al. Prevalence of peripheral neuropathy, amputation, and quality of life in patients with diabetes mellitus. Sci.Rep.. 14 (1), 14430 (2024).
McDaid, D., Park, A. L. & Chadha, S. Estimating the global costs of hearing loss. Int. J. Audiol. 60 (3), 162–170 (2021).
Molnár, A., Maihoub, S., Mavrogeni, P., Tamás, L. & Szirmai, Á. Depression scores and quality of life of vertiginous patients, suffering from different vestibular disorders. Eur. Arch. Otorhinolaryngol. 279, 5173–5179 (2022).
Mendel, B., Bergenius, J. & Langius, A. Dizziness symptom severity and impact on daily living as perceived by patients suffering from peripheral vestibular disorder. Clin. Otolaryngol. Allied Sci. 24 (4), 286–293 (1999).
Möhwald, K. et al. Health-related quality of life and functional impairment in acute vestibular disorders. Eur. J. Neurol. 27, 2089–2098 (2020).
Nayeni, M., Dang, A., Mao, A. J. & Malvankar-Mehta, M. S. Quality of life of low vision patients: a systematic review and meta-analysis. Can. J. Ophthalmol. 56 (3), 151–157 (2021).
Tan, Y., Fang, L., Zhu, Y. & Hashimoto, K. Relationship between hearing loss and depression: A cross-sectional analysis from the National health and nutrition examination survey 2015–2018. J. Psychiat. Res. 178, 1–7 (2024).
Sacknovitz, Y. et al. Association between multisensory impairment and depression among older adults: A Population-Based analysis. Otolaryngol. Head Neck Surg. 171, 115–123 (2024).
Rees, G. et al. Association between Diabetes-Related eye complications and symptoms of anxiety and depression. JAMA Ophthalmol. 134 (9), 1007–1014 (2016).
Bartoli, F. et al. Association between depression and neuropathy in people with type 2 diabetes: a meta-analysis. Int. J. Geriatr. Psychiatry. 31, 829–836 (2018).
Bigelow, R. T., Semenov, Y. R., du Lac, S., Hoffman, H. & Agrawal, Y. Vestibular vertigo and comorbid cognitive and psychiatric impairment: the 2008 National health interview survey. J. Neurol. Neurosurg. Psychiatry. 87, 367–372 (2016).
Chen, X. et al. Peripheral vertigo and subsequent risk of depression and anxiety disorders: a prospective cohort study using the UK biobank. BMC Med. 22, 63 (2024).
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Publishing, 2013).
Fortuna, D. & Golonka, K. When you avoid your feelings, you May feel even worse: how depersonalization puts you at risk of depression. Front. Psychiat. 15, 1481439 (2024).
Ciaunica, A., Seth, A., Limanowski, J., Hesp, C. & Friston, K. J. I overthink—Therefore I am not: an active inference account of altered sense of self and agency in depersonalisation disorder. Conscious. Cognition. 101, 103320 (2022).
Jáuregui-Renaud, K. et al. Quality of sleep and mental symptoms contribute to health-related quality of life after covid-19 pneumonia, a follow-up study of more than 2 years. Biomedicines 12 (7), 1574 (2024).
Mula, M., Pini, S. & Cassano, G. B. The neurobiology and clinical significance of depersonalization in mood and anxiety disorders: A critical reappraisal. J. Affect. Disord. 99, 91–99 (2007).
Jáuregui-Renaud, K., Ramos-Toledo, V., Aguilar-Bolaños, M. & Montaño-Velázquez, B. Pliego-Maldonado, A. Symptoms of detachment from the self or from the environment in patients with an acquired deficiency of the special senses. J. Vestib. Res. 18 (2–3), 129–137 (2008).
Hunter, E. C., Sierra, M. & David, A. S. The epidemiology of depersonalisation and derealisation. A systematic review. Soc. Psychiatry Psychiatr. Epidemiol. 39 (1), 9–18 (2004).
Schlax, J. et al. Symptoms of depersonalisation/derealisation are independent risk factors for the development or persistence of psychological distress in the general population: results from the Gutenberg health study. J. Affect. Disord. 273, 41–47 (2020).
Atchley, R. & Bedford, C. Dissociative symptoms in posttraumatic stress disorder: a systematic review. J. Trauma. Dissociation: Off. J. Int. Soc. Study Dissociation (ISSD). 22 (1), 69–88 (2021).
Kontoangelos, K. et al. Burnout related to diabetes mellitus: A critical analysis. Clin. Pract. Epidemiol. Ment. Health. 18, e174501792209010 (2022).
Moffatt, J. A. et al. Dissociative experiences arise from disrupted multi-sensory integration. PsyArXiv https://doi.org/10.31234/osf.io/e5z74 (2024).
Cohen, J. Statistical power analysis. Curr. Dir. Psychol. Sci. 1, 98–101 (1992).
Jáuregui-Renaud, K., Gutiérrez, M. A., Viveros, R. L. & Villanueva, P. L. Síntomas de inestabilidad corporal y enfermedad vestibular. Rev. Med. Inst. Mex Seguro Soc. 41, 373–378 (2003).
Zigmond, A. S. & Snaith, R. P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67, 361–370 (1983).
Bjelland, I., Dahl, A. A., Haug, T. T. & Neckelmann, D. The validity of the hospital anxiety and depression scale. An updated literature review. J. Psychos. Res. 52, 69–77 (2002).
Cox, B. J. & Swinson, R. P. Instrument to assess depersonalization-derealization in panic disorder. Depress. Anxiety. 15, 172–175 (2002).
Bernstein, E. M. & Putnam, F. W. Development, reliability, and validity of a dissociation scale. J. Nerv. Ment Dis. 174, 727–735 (1986).
Robles Garcia, R., Rico, G., Paez Agraz, F. & S.E. & Evaluación de Trastornos disociativos En Población Psiquiátrica mexicana: prevalencia, comorbilidad y características Psicométricas de La Escala de experiencias disociativas. Salud Mental. 29, 38–43 (2006).
McHorney, C. A., Ware, J. E. Jr & Raczek, A. E. The MOS 36-Item Short-Form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med. Care. 31, 247–263 (1993).
Ware, J. E., Kosinski, M. & Keller, S. D. SF-36 Physical and Mental Health Summary Scales: A User’s Manual (The Health Institute, 1994).
Bjorner, J. B., Wolden, M. L., Gundgaard, J. & Miller, K. A. Benchmarks for interpretation of score differences on the SF-36 health survey for patients with diabetes. Value Health. 16, 993–1000 (2013).
Feldman, E. L. & Stevens, M. J. Clinical testing in diabetic peripheral neuropathy. Can. J. Neurol. Sci. 21 (4), S3–7 (1994).
Kumar, S. et al. Semmes-Weinstein monofilaments: A simple effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res. Clin. Pract. 13, 63–68 (1991).
Clark, J. G. Uses and abuses of hearing loss classification. ASHA 23, 493–500 (1981).
Alizadeh, Y., Jalali, M. M. & Sehati, A. Association of different severity of diabetic retinopathy and hearing loss in type 2 diabetes mellitus. Am. J. Otolaryngol. Head Neck Med. Surg. 43, 103383 (2022).
Ward, B. K. et al. Characterization of vestibulopathy in individuals with type 2 diabetes mellitus. Otolaryngol. Head Neck Surg. 153, 112–118 (2015).
Jáuregui-Renaud, K., Cabrera-Pereyra, R., Miguel-Puga, J. A. & Alcántara-Thome, M. Graviception uncertainty, Spatial anxiety, and derealization in patients with persistent Postural-Perceptual Dizziness. J. Clin. Med. 13, 6665 (2024).
Senkowski, D. & Engel, A. K. Multi-timescale neural dynamics for multisensory integration. Nat. Rev. Neurosci. 25, 625–642 (2024).
Friston, K. The free-energy principle: a rough guide to the brain? Trends Cogn. Sci. 13, 293–301 (2009).
Yao, L. et al. A multimodal meta-analysis of regional structural and functional brain alterations in type 2 diabetes. Front. Neuroendocrinol. 62, 100915 (2021).
Balaban, C. D., Jacob, R. G. & Furman, J. M. Neurologic bases for comorbidity of balance disorders, anxiety disorders, and migraine: neurotherapeutic implications. Expert Rev. Neurother. 11 (3), 379–394 (2011).
Nouwen, A. et al. Longitudinal associations between depression and diabetes complications: a systematic review and meta-analysis. Diabet. Med. 36 (12), 1562–1572 (2019).
Farooqi, A. et al. A systematic review and meta-analysis to compare the prevalence of depression between people with and without type 1 and type 2 diabetes. Prim.Care Diabetes. 16 (1), 1–10 (2022).
Maina, J. G. et al. Bidirectional Mendelian randomization and multiphenotype GWAS show causality and shared pathophysiology between depression and type 2 diabetes. Diabetes Care. 46 (9), 1707–1714 (2023).
Luppino, F. S. et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch. Gen. Psychiatry. 67 (3), 220–229 (2010).
Sen, Z. D. et al. Linking atypical depression and insulin resistance-related disorders via low-grade chronic inflammation: integrating the phenotypic, molecular and neuroanatomical dimensions. Brain Behav. Immun. 93, 335–352 (2021).
Penninx, B. W. et al. Immuno-metabolic depression: from concept to implementation. Lancet Region Health–Eur. 48, 101166 (2025).
Proulx, M. J., Todorov, O. S., Taylor Aiken, A. & de Sousa, A. A. Where am I? Who am I? The relation between Spatial cognition, social cognition and individual differences in the built environment. Front. Psychol. 7, 64 (2016).
Mast, F. W., Preuss, N., Hartmann, M. & Grabherr, L. Spatial cognition, body representation and affective processes: the role of vestibular information beyond ocular reflexes and control of posture. Front. Integr. Neurosci. 8, 44 (2014).
Sang, Y. P. F., Jáuregui-Renaud, K., Green, D. A., Bronstein, A. M. & Gresty, M. A. Depersonalization/ derealization symptoms in vestibular disease. J. Neurol. Neurosurg. Psychiatry. 77 (6), 760–766 (2006).
Pfeiffer, C., Serino, A. & Blanke, O. The vestibular system: a Spatial reference for bodily self-consciousness. Front. Integr. Neurosci. 8, 31 (2014).
Ackerley, R. Somatosensation and Body Perception: the Integration of Afferent Signals in Multisensory Cognitive Processes in Cognitive Archaeology, Body Cognition, and the Evolution of Visuospatial Perception (Academic, 2023).
Deane, G., Miller, M. & Wilkinson, S. Losing ourselves: active inference, depersonalization, and meditation. Front. Psychol. 11, 539726 (2020).
Gatus, A., Jamieson, G. & Stevenson, B. Past and future explanations for depersonalization and derealization disorder: a role for predictive coding. Front. Hum. Neurosci. 16, 744487 (2022).
Seedat, S., Stein, M. & Forde, D. R. Prevalence of dissociative experiences in a community sample: relationship to gender, ethnicity, and substance use. J. Nerv. Mental Dis. 191 (2), 115–120 (2003).
Khil, L., Wellmann, J. & Berger, K. Impact of combined sensory impairments on health-related quality of life. Qual. Life Res. 24, 2099–2103 (2015).
World Health Organization. Childhood Hearing Loss: Strategies for Prevention and Care. Report No: 9241510323. World Report on Hearing (World Health Organization, 2021).
Cohen, B. E., Durstenfeld, A. & Roehm, P. C. Viral causes of hearing loss: a review for hearing health professionals. Trends Hear. 18, 2331216514541361 (2014).
Marchetti, G. F., Whitney, S. L., Redfern, M. S. & Furman, J. M. Factors associated with balance confidence in older adults with health conditions affecting the balance and vestibular system. Arch. Phys. Med. Rehabil. 92 (11), 1884–1891 (2011).
Fritschi, C. & Quinn, L. Fatigue in patients with diabetes: A review. J. Psychosom. Res. 69 (1), 33–41 (2010).
Liu, X. et al. Anxiety and depression in diabetes care: longitudinal associations with health-related quality of life. Sci. Rep. 10, 8307 (2020).
Hohls, J. K., König, H. H., Quirke, E. & Hajek, A. Anxiety, depression and quality of life—a systematic review of evidence from longitudinal observational studies. Int. J. Environ. Res. Public. Health. 18 (22), 12022 (2021).
Stephenson, J., Smith, C. M., Kearns, B., Haywood, A. & Bissell, P. The association between obesity and quality of life: a retrospective analysis of a large-scale population-based cohort study. BMC Public. Health. 21, 1–9 (2021).
Abiri, B., Hosseinpanah, F., Banihashem, S., Madinehzad, S. A. & Valizadeh, M. Mental health and quality of life in different obesity phenotypes: a systematic review. Health Qual. Life Outcomes. 20 (1), 63 (2022).